483 David J. De La Zerda, MD Jan 2021

483 David J. De La Zerda, MD Jan 2021

Richard Lyght FDA$119.00 - Available Now

FDA investigators audited the David J. De La Zerda, MD - Miami, FL, United States facility and issued inspectional observations (via FDA 483) on 13 Jan 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Jan 2021
  • Location: Miami, United States
  • FEI: 3017619551
Add To Cart